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Background: Severe malaria may be complicated by the acute respiratory distress syndrome (ARDS), which is
associated with a high mortality. In the present report, a series of three cases of imported malaria complicated by
refractory severe ARDS supported with extracorporeal membrane oxygenation (ECMO) is presented.
Methods: One female and two male adult patients (ages 39 to 53) were included. Two patients had Plasmodium
falciparum infection and one patient had Plasmodium vivax and Plasmodium ovale co-infection. Anti-malarial
therapy consisted in intravenous quinine (in two patients) and intravenous quinidine (in one patient), plus
clindamycin or doxycycline.
Results: Despite lung protective ventilation, a conservative strategy of fluid management, corticosteroids
(two patients), prone position (two patients) and inhaled nitric oxide (one patient), refractory severe ARDS
supervened (PaO2 to FiO2 ratio 68) and venovenous ECMO was then initiated. In one patient, a bicaval dual-lumen
cannula was inserted; in the two other patients, a two-site configuration was used. Two patients survived to
hospital-discharge (duration of ECMO support: 8.5 days) and one patient died from nosocomial sepsis and
multi-organ failure after 40 days of ECMO support.
Conclusions: ECMO support allowed adequate oxygenation and correction of hypercapnia under lung protective
ventilation, therefore reducing ventilator-induced lung injury. ECMO referral should be considered early in malaria
complicated by severe ARDS refractory to conventional treatment.
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Malaria is responsible for more than one million deaths
annually, the majority of which occur in sub-Saharan
Africa, with Plasmodium falciparum as the predominant
organism [1]. In non-endemic regions, most cases occur
in non-immune or semi-immune travellers returning
from endemic countries who do not adhere to malaria
chemoprophylaxis [2,3]. Such cases may be particularly
severe, with in-hospital mortality rates reported as 11 to* Correspondence: hdb5@columbia.edu
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reproduction in any medium, provided the or40% [2,4-6]. Acute respiratory distress syndrome (ARDS),
which may develop in either the acute or late phases of
infection, has been reported in 5 to 25% of adults with se-
vere P. falciparum and in 1 to 10% of patients with severe
Plasmodium vivax [1], with an attributable mortality of
20% in developed countries [5].
Extracorporeal membrane oxygenation (ECMO), refer-
ring to an extracorporeal circuit that directly oxygenates
and removes carbon dioxide from the blood, may be
considered in patients with ARDS whose pulmonary
injury is so severe that positive-pressure ventilation alone
is insufficient to maintain adequate gas exchange, or when
adherence to lung-protective ventilation strategies results
in unacceptable levels of hypercapnia and acidaemia [7]. Intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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is utilized, in which blood is withdrawn from and returned
to a central vein. Recently, there has been increasing inter-
est in ECMO as a result of advances in extracorporeal tech-
nology, with more efficient oxygenators and lower rates of
complications, along with several reports of improved
survival with ECMO for severe ARDS [8-11]. However,
reports of ECMO for severe ARDS in patients with
malaria are uncommon, with only two cases reported
separately in the literature [5,12], as well as one case of
extracorporeal carbon dioxide elimination [13]. In the
present report, a series of three cases of malaria compli-
cated by severe ARDS refractory to conventional treat-
ment and supported with ECMO is presented.
Methods
Case 1
A 53-year-old Portuguese man with a history of diabetes
and myocardial infarction presented with five days of fever,




Country of origin Angola
Plasmodium species P. falciparum
Clinical deterioration (days)
Symptoms to hospital admission 5
Hospital to ICU admission 2
ICU admission to ECMO 9









Renal replacement therapy Yes
APACHE II * 11
Mechanical ventilation (days) 48
ECMO (days) 40
ICU LOS (days) 49
ICU survival NSurv
Hospital survival NSurv
APACHE II, Acute Physiology and Chronic Health Evaluation II; LOS, length of stay; E
ventilation; NSurv, non-survivor; Surv, survivor. * First day of ICU admission.been living in Angola, and he was not taking any malaria
prophylaxis. The patient was evaluated at Hospital S
João (Porto, Portugal), where vital signs and physical
examination were unremarkable. Blood smear revealed
P. falciparum (2% parasitaemia) and severe thrombo-
cytopaenia (17,000 platelets/μl). The patient was initially
admitted in a regular ward and oral quinine sulphate
plus doxycycline were administered. However, shortly
after admission, he developed vomiting with intolerance
to oral drugs. In that context, intravenous quinine and
doxycycline were started. No arrhythmia occurred during
quinine treatment. The patient developed progressive hyp-
oxemic respiratory failure requiring invasive mechanical
ventilation (IMV) on hospital day 3 despite antimicrobials,
diuresis, and clearance of his parasitaemia (Table 2). Blood
cultures (obtained on hospital and ICU admission), urine
culture and pneumococcal and Legionella urinary antigen
tests, bacteriologic and virologic exams of tracheal secre-
tions and bronchoalveolar lavage (performed immediately























CMO, extracorporeal membrane oxygenation; IMV, invasive mechanical
Table 2 Respiratory and haematologic parameters before,
during, and after ECMO
Patient 1 2 3
ICU admission
Ventilation SB NIV IMV
FiO2 (%) 85 50 100
pH / PaCO2 (mmHg) 7.50 / 36.2 7.41 / 39.4 7.41/39
Haemoglobin (g/dL) 11.4 12.0 9.6
Parasitaemia (%) Negative Negative 0.015
Before ECMO
PC-peak / VC-plat (cmH2O) 32 30 34
Tidal volume (ml) 420 450 350
PEEP (cmH2O) 13 12 15
PaO2 / FiO2 (mmHg) 69 62 69
FiO2 (%) 100 100 100
pH / PaCO2 (mmHg) 7.36 / 72.9 7.35 / 73.1 7.41 / 39.0
Fluid balance (L/24h) +0.35 +0.75 +0.52
Day 2 on ECMO
PC-peak / VC-plat (cmH2O) 28 26 26
Tidal volume (ml) 280 340 210
PEEP (cmH2O) 10 10 10
FiO2 (%) 60 55 40
ECMO-BF (lpm) 3.0 3.0 3.5
ECMO-sweep (lpm) 2.0 3.0 3.0
pH / PaCO2 (mmHg) 7.40 / 47.0 7.44 / 54.0 7.45 / 36.0
Fluid balance (L/24h) +1.55 +0.85 +2.70
End of ECMO
PC-peak / VC-plat (cmH2O) 31 28 23
Tidal volume (ml) 110 560 385
PEEP (cmH2O) 8 8 12
FiO2 (%) 60 50 50
ECMO-BF (lpm) 3.0 3.0 3.3
ECMO-sweep (lpm) 7.0 2.5 1.5
pH / PaCO2 (mmHg) 7.22 / 33.0 7.43 / 38.5 7.43/42
Fluid balance (L/24h) +1.85 +0.80 +0.48
ICU discharge
Ventilation NA SB SB
FiO2 (%) NA 27 40
pH / PaCO2 (mmHg) NA 7.47 / 30.7 7.44 / 38.0
ECMO-BF, blood flow through the ECMO circuit; ECMO-Sweep, sweep gas flow
through the ECMO circuit; IVM, invasive mechanical ventilation; NA, not
applicable; NIV, non-invasive ventilation; PaCO2, arterial carbon dioxide partial
pressure; PEEP, positive end-expiratory pressure; PC-peak, peak inspiratory
pressure under pressure control ventilation; SB, spontaneous breathing;
VC-plat, plateau pressure under volume control ventilation.
A
B
Figure 1 Thoracic computed tomography (CT) before ECMO
implantation (A) and after 40 days of ECMO support (B) in Patient
1. A. Bilateral parenchymal consolidation in gravity-dependent areas
and ground-glass-appearing opacities of lung parenchyma, compatible
with severe ARDS. B. Extensive parenchymal consolidation and bilateral
pleural effusions with associated compression atelectasis after 40 days
of VV-ECMO.
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in gravity-dependent areas and ground-glass-appearing
opacities of lung parenchyma, compatible with severeARDS (Figure 1A). Echocardiography was performed
showing preserved ejection fraction and normal diastolic
function. Moreover, plasma BNP was not elevated
(98 pg/ml). Haemodynamic monitoring using the
transpulmonary thermodilution technique and arterial
pulse contour analysis (PiCCO®; Philips) was also
performed before ECMO treatment, the results being
consistent with ARDS (increased (23.7; normal range
3.0-7.0 ml/kg) extravascular lung water index (ELWI) and
increased (6.6; normal range 1.0-3.0) pulmonary vascular
permeability index (PVPI)), without intravascular volume
overload (decreased (672; normal range 850–1000 ml/m2)
intrathoracic blood volume index (ITBI) and decreased
(538; normal range 680–800 ml/m2) global enddiastolic
volume index (GEDI)). Cardiac index (3.6; normal range
3.0 - 5.0 l/min/m2) and systemic vascular resistance index
AB
Figure 2 Chest X-ray before ECMO implantation (A) and before
hospital discharge (B) in Patient 2. A. Bilateral parenchymal
consolidation with air bronchograms, compatible with severe ARDS.
B. Complete resolution of bilateral infiltrates.
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recorded. On day 7 of IMV, his PaO2 was 69 mmHg with
a FiO2 of 1.0 and PEEP of 13 cm of water, without im-
provement with a conservative strategy of fluid man-
agement, prone positioning or corticosteroids. ECMO
was initiated with placement of a 21Fr right femoral venous
drainage cannula and a 15Fr right internal jugular
venous re-infusion cannula. The ventilator was then
set to a lung-protective strategy (Table 2). On hospital
day 20, ventilator-associated pneumonia occurred and
Pseudomonas aeruginosa was isolated in cultures from
bronchoalveolar lavage and blood. On hospital day 40
a new episode of VAP occurred and Escherichia coli
was isolated in cultures from tracheal aspirate and on
hospital day 48 septic shock with multi-organ failure
supervened and Pseudomonas aeruginosa was isolated
from the blood and tracheal aspirate. The patient died
on hospital day 49 (ECMO day 40; Figure 1B). The only
ECMO-related complication was thrombus formation in
the oxygenator, requiring exchange on ECMO day 29.
Case 2
A 39-year-old Portuguese man with a history of hyper-
tension and a prior episode of malaria treated as an out-
patient, presented with three days of fever, myalgias,
headache, nausea and vomiting (Table 1). The patient
had worked for several years in Mozambique, and he
was not taking any malaria prophylaxis. On presentation,
he was febrile and somnolent. Chest X-ray was normal.
Blood smear revealed P. falciparum (3% parasitaemia) and
thrombocytopaenia (80,000 platelets/μl). Taking into
account the presence of vomiting with intolerance to
oral drugs, the patient was treated with intravenous
quinine and clindamycin. Despite negative cultures and
clearance of his parasitaemia, hypoxemic respiratory fail-
ure developed on hospital day 6, requiring IMV (Table 2).
Blood cultures (obtained on hospital and ICU admission),
urine culture and urinary antigens (pneumococcal and
Legionella), bacteriologic and virologic examinations of
tracheal secretions and bronchoalveolar lavage (performed
immediately after tracheal intubation) were all negative.
Chest X-ray showed bilateral infiltrates and echocardio-
gram was unremarkable (Figure 2A). On day 11 of IMV,
his PaO2 was 62 mmHg despite an FIO2 of 1.0, PEEP of
12 cm of water, a conservative strategy of fluid manage-
ment, prone positioning, and corticosteroids. ECMO
was then initiated with a 23Fr drainage cannula in the
right femoral vein and 17Fr re-infusion cannula in the
right internal jugular vein. The patient was successfully
decannulated after seven days of ECMO support and
weaned off IMV within the next seven days (Figure 2B).
There were no ECMO-related complications. He was
discharged home two weeks post-ICU discharge, where
he has been living independently.Case 3
A 46-year-old American woman presented with two weeks
of cyclic fevers, night sweats, and myalgias (Table 1). She
had recently returned from Uganda, where she worked in a
rural area and was adherent to atovaquone and progua-
nil malaria prophylaxis. She was treated empirically for
chloroquine-resistant P. falciparum with oral quinine
and doxycycline, however she did not tolerate oral ther-
apy due to nausea and vomiting, and required admission
to a local hospital for initiation of intravenous quinidine
and clindamycin. Her vital signs, physical exam, and
chest X-ray were unremarkable. Initial blood smears
showed 0.5% parasitaemia. Once PCR testing confirmed
P. vivax and P. ovale and excluded P. falciparum, her
treatment was changed to chloroquine; however severe
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developed by hospital day 4, requiring IMV, at which
point intravenous therapy was resumed. PaO2 was 68
mmHg despite an FIO2 of 1.0, PEEP of 15 cm of water, a
conservative strategy of fluid management and inhaled
nitric oxide (iNO) (Table 2). Echocardiogram demon-
strated normal cardiac function. She was transferred to the
Columbia University College of Physicians and Surgeons
(New York, NY, USA), where she was placed on ECMO
with a 27Fr bicaval dual-lumen cannula via the right
internal jugular vein under fluoroscopic and echocar-
diographic guidance [14,15]. Cultures and blood smears
in the ICU were negative for organisms. Anti-malarial
therapy with intravenous quinidine and doxycycline was
continued and she was successfully decannulated on
ECMO day 10, and liberated from IMV seven days later.
No arrhythmias occurred during quinine treatment. One
month post-discharge, she was functioning independently.
Two ECMO-related complications occurred: i) migration
of the distal end of the cannula into a hepatic vein, identi-
fied by transesophageal echocardiogram on ECMO day 2 in
the setting of a decrease in blood flow rates, followed by
successful repositioning at the bedside; and ii) bleeding
from the cannulation site and epistaxis that required a total
of 8 units of packed red blood cells in the setting of low-
level anticoagulation to maintain ECMO circuit integrity
(mean activated partial thromboplastin time 46.5 seconds).
Consent
Informed consent was obtained from the patients for
publication of this case series and any accompanying
images after explanation of the report objectives.
Discussion
In this report, three cases of imported malaria complicated
by severe ARDS supported with ECMO are presented.
Severe ARDS may be a complication of P. falciparum,
P. vivax or P. ovale infections. In accordance with the
WHO guidelines the presence of ARDS is a defining
criterion for severe malaria [16]. In all three cases, oxygen-
ation and CO2 clearance through the membrane ECMO
lung allowed the compliance to protective ventilation of the
native lung with low tidal volumes (<6 ml/kg IBW) and
low-fractional oxygen concentrations, limiting ventilator-
induced lung injury [17]. However, permissive hypercapnia
is frequently necessary to allow low tidal volume protective
ventilation in severe ARDS. This could be potentially harm-
ful in patients with severe malaria, given that cerebral
oedema with elevated intracranial pressures can complicate
cerebral malaria [18] and that hypercapnia causes cerebral
vasodilatation and intracranial pressure elevation. More-
over, microvascular congestion and sequestration of parasit-
ized red blood cells was shown to be a common feature in
cerebral malaria, leading to impaired tissue perfusion thatmay cause diffuse cerebral ischemia and increased intracra-
nial blood volume [19]. The use of ECMO in patients with
severe malaria, allowing strict control of patient’s PaCO2,
potentially limits intracranial pressure elevation.
Fluid management is crucial in patients with severe
malaria. Taking into account that in these patients pul-
monary edema secondary to increased pulmonary vascular
permeability has been shown to be frequent, unpredictable
and exacerbated by fluid loading, a conservative strategy
of fluid management was followed in all three patients
before and after ECMO initiation [20]. Moreover, a liberal
strategy of fluid management in acute lung injury has been
previously associated with prolonged duration of mechan-
ical ventilation and intensive care [21].
ECMO is not without risks and there are no definitive
criteria for ECMO treatment in adult ARDS. Therefore,
ECMO should only be considered in adult patients
with malaria and severe ARDS refractory to conven-
tional treatment. The recently conducted CESAR trial
showed favourable results of ECMO referral for adult
patients with severe ARDS [8]. In that context, the same
inclusion (Murray score >3.0 or pH <7.20) and exclusion
(high pressure (>30 cm H2O of peak inspiratory pressure)
or high FiO2 (>0.8) ventilation for more than seven days;
intracranial bleeding; any other contraindication to limited
heparinization) criteria for ECMO consideration in malaria
and severe ARDS were used in the present case series.
Severe imported malaria is an important problem in the
western world due to the increasing number of travellers
returning from endemic countries who are non-adherent to
malaria chemoprophylaxis [22]. Most imported cases occur
in non-immune patients in whom malaria can rapidly pro-
gress to severe disease, with mortality as high as 20 to 35%,
even with adequate anti-malarial treatment [23]. ARDS
may develop in isolation or as part of a severe multisystem
illness and often occurs within a few days of starting treat-
ment when parasitaemia is falling [24]. The pathogenesis of
ARDS in malaria is not fully understood, though it may
involve parasite sequestration in the pulmonary vasculature
and up-regulation of pro-inflammatory cytokines, and may
persist even after parasite clearance [1]. However, parasite
sequestration in the pulmonary vasculature seems to be
relevant only for P. falciparum infection, given that in
P. vivax malaria there is no substantial lung sequestration.
Severe ARDS in patients with malaria has a poor progno-
sis, with mortality as high as 69 to 95% in observational
ICU case series [22,25]. Severe ARDS most commonly
complicates P. falciparum infection and is rarely a com-
plication of P. vivax or P. ovale infection. This could be
related to differences in cyto-adhesion of infected eryth-
rocytes [26-29]. However, it should be stressed that it is
difficult to definitely establish malaria as the sole etiology
for severe ARDS, fully excluding bacterial co-infection.
Nevertheless, no documentation of bacterial co-infection
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tion and culture at ICU admission. This could support the
assumption that malaria was the most probable cause for
severe ARDS in the three cases presented in this report.
Risk factors associated with the development of ARDS
in malaria include advanced age, lack of specific immunity,
immunocompromised status, and pregnancy. A high
parasitic burden is not necessary [30]. In this case series,
patients were either semi-immune or non-immune and
parasitaemia was less than 4% in all patients.
There are only two prior cases reported separately on
the use of ECMO for severe ARDS in patients with malaria,
as well as one case on the use of extracorporeal carbon
dioxide elimination [5,12,13]. In both cases of ECMO
use, P. falciparum was identified as the causal organism
and ECMO was instituted within seven days for refrac-
tory hypoxaemia, but only one patient survived [5,12].
In the case of extracorporeal carbon elimination use,
P. falciparum was also identified as the causal organism
and extracorporeal carbon elimination was instituted
on the 17th day, being discontinued after twelve days.
The patient was weaned from mechanical ventilation
and successfully discharged home [13]. In the present
case series, one of the two patients that initiated ECMO
after more than seven days of IMV did not survive. Patients
with ARDS who have been receiving IMV with excessively
high plateau pressures or high fractions of inspired oxygen
for more than seven days may be less likely to benefit from
ECMO [31-35]. Earlier initiation of ECMO, for these or
other reasons, has been associated with better outcomes in
some, but not all, observational studies [33,36-38].
Patients with severe forms of malaria are highly sus-
ceptible to bacterial infections and concomitant anti-
bacterial therapy is recommended [2,39]. All the three
patients presented in this case series received adequate
antimicrobial therapy, though one patient developed
nosocomial infections and ultimately died of sepsis,
despite appropriate antibacterial coverage.
ECMO-related complications in the present case series
included cannula migration into a hepatic vein, which
was identified by transesophageal echocardiogram and
corrected at the bedside. Thrombus formation in the
oxygenator was ultimately the cause for oxygenator ex-
change in one patient. However, the rate of thrombosis-
associated oxygenator failure requiring device exchange
is low, even at low levels of anticoagulation [14]. Major
bleeding complications, as occurred in one patient, are
less frequent in the era of modern ECMO technology,
given the ability to maintain circuit integrity at lower
levels of anticoagulation, but they may still occur, espe-
cially in the setting of pre-existing thrombocytopaenia
or coagulopathy.
In conclusion, severe ARDS can complicate P. falciparum,
P. vivax, and P. ovale infection. In regions where thetechnology is available, ECMO referral should be consid-
ered for patients with malaria complicated by severe ARDS
refractory to conventional treatment. Taking into account
the limited experience with ECMO in severe malaria yet, its
use should be performed in experienced ECMO centers. In
fact, severe malaria can cause haemolysis, disseminated
intravascular coagulation and low platelets, which might be
exaggerated by the use of extracorporeal devices.
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